Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by WalkingonNailson Dec 14, 2016 3:30pm
292 Views
Post# 25600184

Positive outlook going forward for longs only (FOEOEIBB)

Positive outlook going forward for longs only (FOEOEIBB)- Easing of FDA drug approvals was cleared by senate will speed up new drug approvals

- DT will move to jumpstart FDA drug approvals even faster especially NEW drugs
https://www.washingtonexaminer.com/trump-will-move-to-jumpstart-fda-drug-approval-process/article/2608610

- By Mid-2017 Plasminogen should be on the market (99.99%) or possibly sooner generating revenue. Then we can look forward to IVIG.

- Possible regional/specialty partnering on PBI series or/and Plasminogen.

- Management/Directors have learned from past mistakes made? and will correct them going forward! Hopefully remains to be seen!

- Many insiders are buying PLI at these lower levels currently does show some confidence going forward.

So far the firewall at 1.88$ is holding(52 week low = about half 52 week high) , the non-believers are being squeezed until the last drop!

ALL ABOVE IMO
GLTA

Bullboard Posts